Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 6
2005 17
2006 15
2007 15
2008 20
2009 16
2010 11
2011 17
2012 17
2013 15
2014 35
2015 22
2016 6
2019 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

193 results
Results by year
Filters applied: . Clear all
Page 1
Peripheral T-cell lymphomas.
Macon WR. Macon WR. Hematol Oncol Clin North Am. 2009 Aug;23(4):829-42. doi: 10.1016/j.hoc.2009.04.007. Hematol Oncol Clin North Am. 2009. PMID: 19577171 Review.
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL. Parrilla Castellar ER, et al. Blood. 2014 Aug 28;124(9):1473-80. doi: 10.1182/blood-2014-04-571091. Epub 2014 Jun 3. Blood. 2014. PMID: 24894770 Free PMC article.
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.
Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL, Novak AJ, Dogan A, Ansell SM, Link BK, Zou L, Gould J, Saksena G, Stransky N, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Hernández-Lemus E, Schwarz-Cruz y Celis A, Imaz-Rosshandler I, Ojesina AI, Jung J, Pedamallu CS, Lander ES, Habermann TM, Cerhan JR, Shipp MA, Getz G, Golub TR. Lohr JG, et al. Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3879-84. doi: 10.1073/pnas.1121343109. Epub 2012 Feb 17. Proc Natl Acad Sci U S A. 2012. PMID: 22343534 Free PMC article.
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy.
Maurer MJ, Ghesquières H, Jais JP, Witzig TE, Haioun C, Thompson CA, Delarue R, Micallef IN, Peyrade F, Macon WR, Jo Molina T, Ketterer N, Syrbu SI, Fitoussi O, Kurtin PJ, Allmer C, Nicolas-Virelizier E, Slager SL, Habermann TM, Link BK, Salles G, Tilly H, Cerhan JR. Maurer MJ, et al. J Clin Oncol. 2014 Apr 1;32(10):1066-73. doi: 10.1200/JCO.2013.51.5866. Epub 2014 Feb 18. J Clin Oncol. 2014. PMID: 24550425 Free PMC article. Clinical Trial.
Host genetics in follicular lymphoma.
Cerhan JR. Cerhan JR. Best Pract Res Clin Haematol. 2011 Jun;24(2):121-34. doi: 10.1016/j.beha.2011.02.004. Epub 2011 May 5. Best Pract Res Clin Haematol. 2011. PMID: 21658613 Free PMC article. Review.
Cancer immunotherapy comes of age.
Topalian SL, Weiner GJ, Pardoll DM. Topalian SL, et al. J Clin Oncol. 2011 Dec 20;29(36):4828-36. doi: 10.1200/JCO.2011.38.0899. Epub 2011 Oct 31. J Clin Oncol. 2011. PMID: 22042955 Free PMC article. Review.
193 results